Physician profile
Kenneth K Sha
NPI 1821097932
$25,938.96
in general payments reported to CMS, 2019-2025
43 companies · $4,179 in 2025
The $4,179 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,503 · 2020: $2,414 · 2021: $4,028 · 2022: $3,937 · 2023: $4,101 · 2024: $3,778 · 2025: $4,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,615.11 |
| Education | $442.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,949.07 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,225.72 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $3,112.82 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Mallinckrodt Hospital Products INC. | $3,108.84 | 2020-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $1,863.91 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $1,414.86 | 2019-2025 | Opsumit, Uptravi |
| Insmed, INC. | $1,382.50 | 2019-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $849.98 | 2019-2025 | Smartvest |
| Genentech USA, INC. | $652.61 | 2019-2024 | Xolair |
| Philips North America LLC | $644.59 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $641.27 | 2022-2025 | Tezspire, Krystexxa, Tavneos |
| Mylan Specialty L.P. | $592.75 | 2019-2024 | Yupelri |
| Baxter Healthcare | $404.07 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Advanced Respiratory, INC | $353.56 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $329.51 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $317.77 | 2019-2021 | |
| Verona Pharma, INC. | $312.26 | 2025 | Ohtuvayre |
| Abbvie INC. | $253.82 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $236.36 | 2020-2025 | Glassia, Aralast |
| Novo Nordisk INC | $223.55 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $221.82 | 2019-2022 | |
| Lilly USA, LLC | $200.17 | 2019-2023 | Mounjaro |
| Genzyme Corporation | $193.21 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $167.46 | 2023-2025 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $157.95 | 2019-2023 | Tyvaso |
| Merck Sharp & Dohme LLC | $128.71 | 2021-2024 | Keytruda |
| Optinose US, INC. | $123.79 | 2019-2020 | |
| Circassia INC. | $99.30 | 2019 | |
| Viatris Specialty LLC | $96.51 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $86.76 | 2019-2025 | |
| Shire North American Group INC | $80.78 | 2019 | |
| Pfizer INC. | $75.14 | 2019-2021 | |
| Vifor Pharma, INC. | $71.23 | 2025 | Zemaira |
| Jazz Pharmaceuticals INC. | $68.53 | 2020-2021 | |
| Inspire Medical Systems, INC. | $62.30 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $50.80 | 2024 | Voquezna |
| Inogen, INC. | $44.12 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Melinta Therapeutics, LLC | $39.93 | 2021 | |
| Qol Medical, LLC | $30.91 | 2025 | Sucraid |
| 3b Medical, INC. | $21.77 | 2025 | Luna |
| Kowa Pharmaceuticals America, INC. | $19.61 | 2021 | |
| Hikma Pharmaceuticals USA | $15.84 | 2023 | Ryaltris, Mitigare |
| E.R. Squibb & Sons, L.L.C. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Sha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.